Literature DB >> 27038464

Contact Hypersensitivity.

Anthony A Gaspari1, Stephen I Katz1, Stefan F Martin2.   

Abstract

Contact hypersensitivity (CHS) is a simple in vivo assay of cell-mediated immune function in which exposure of epidermal and dermal cells to exogenous haptens results in a delayed-type hypersensitivity (DTH) reaction that can be measured and quantified. Epidermal Langerhans cells and dermal dendritic cells are the critical antigen-presenting cells in this reaction which initiate sensitization to haptens by presenting antigens to CD4- and CD8-bearing T lymphocytes which, in turn, secrete cytokines and recruit other cells to the site of the reaction. In the protocol described here, mice are shaved and the skin of their abdomens is exposed to a hapten. After 5 or 6 days (the afferent phase), the baseline ear thickness is measured prior to initiation of the efferent phase. Finally, the ear is treated epicutaneously with the hapten solution and ear thickness is measured in ∼24 hr. The magnitude of the ear swelling reaction after allergen treatment reflects the strength of the immune response.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Keywords:  allergic contact dermatitis; contact hypersensitivity; delayed-type hypersensitivity (DTH)

Mesh:

Substances:

Year:  2016        PMID: 27038464     DOI: 10.1002/0471142735.im0402s113

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  8 in total

1.  Neutrophil-Derived Myeloperoxidase Facilitates Both the Induction and Elicitation Phases of Contact Hypersensitivity.

Authors:  Anna Strzepa; Cody J Gurski; Landon J Dittel; Marian Szczepanik; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

2.  Skin microbiota of oxazolone-induced contact hypersensitivity mouse model.

Authors:  Kuunsäde Mäenpää; Shuyuan Wang; Marit Ilves; Hani El-Nezami; Harri Alenius; Hanna Sinkko; Piia Karisola
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

3.  Immunomodulatory Effects of Nanoparticles on Skin Allergy.

Authors:  Samreen Jatana; Brian C Palmer; Sarah J Phelan; Lisa A DeLouise
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

4.  Therapeutic potential of lipids obtained from γ-irradiated PBMCs in dendritic cell-mediated skin inflammation.

Authors:  Maria Laggner; Dragan Copic; Lucas Nemec; Vera Vorstandlechner; Alfred Gugerell; Florian Gruber; Anja Peterbauer; Hendrik J Ankersmit; Michael Mildner
Journal:  EBioMedicine       Date:  2020-05-08       Impact factor: 8.143

5.  CX3CR1 Deficiency Attenuates DNFB-Induced Contact Hypersensitivity Through Skewed Polarization Towards M2 Phenotype in Macrophages.

Authors:  Sayaka Otobe; Teruyoshi Hisamoto; Tomomitsu Miyagaki; Sohshi Morimura; Hiraku Suga; Makoto Sugaya; Shinichi Sato
Journal:  Int J Mol Sci       Date:  2020-10-07       Impact factor: 5.923

Review 6.  Roles of Mast Cells in Cutaneous Diseases.

Authors:  Takafumi Numata; Kazutoshi Harada; Susumu Nakae
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

7.  MAPK Phosphatase-1 Deficiency Exacerbates the Severity of Imiquimod-Induced Psoriasiform Skin Disease.

Authors:  Weiheng Zhao; Shuxiu Xiao; Hongjin Li; Tingting Zheng; Jian Huang; Ran Hu; Baohua Zhang; Xinguang Liu; Gonghua Huang
Journal:  Front Immunol       Date:  2018-03-21       Impact factor: 7.561

8.  Black Raspberries and Protocatechuic Acid Mitigate DNFB-Induced Contact Hypersensitivity by Down-Regulating Dendritic Cell Activation and Inhibiting Mediators of Effector Responses.

Authors:  Kelvin Anderson; Nathan Ryan; Arham Siddiqui; Travis Pero; Greta Volpedo; Jessica L Cooperstone; Steve Oghumu
Journal:  Nutrients       Date:  2020-06-06       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.